Martin Marietta v. Vulcan: Four Valuable Drafting and Litigation Lessons for Trade Secret and Non-Compete Lawyers
Continue Reading Martin Marietta v. Vulcan: Four Valuable Drafting and Litigation Lessons for Trade Secret and Non-Compete Lawyers

05072012On Friday, Delaware Chancery Judge Leo Strine, Jr. issued a 100+ page opinion finding that gravel material supplier Martin Marietta Materials “thoroughly breached” confidentiality agreements with competitor Vulcan Materials during merger negotiations and as a result, its effort at a hostile takeover bid would be prohibited for the next four months. It appears that Martin

DeLuca v. DA Peterson: Ohio Court Finds Radio Station’s Non-Compete Does Not Cover Streaming Online Show by Former Morning Show Co-Hosts
Continue Reading DeLuca v. DA Peterson: Ohio Court Finds Radio Station’s Non-Compete Does Not Cover Streaming Online Show by Former Morning Show Co-Hosts

Thursday Wrap-Up (March 29, 2012): Noteworthy Trade Secret, Non-Compete and Cybersecurity Stories from the Web
Continue Reading Thursday Wrap-Up (March 29, 2012): Noteworthy Trade Secret, Non-Compete and Cybersecurity Stories from the Web

Thursday Wrap Up (March 22, 2012): Noteworthy Trade Secrets, Covenant Not to Compete and Cybersecurity Stories on the Web
Continue Reading Thursday Wrap Up (March 22, 2012): Noteworthy Trade Secrets, Covenant Not to Compete and Cybersecurity Stories on the Web

Thursday Wrap-Up (March 15, 2012): Noteworthy Trade Secret, Non-Compete and Cybersecurity Stories from Around the Web
Continue Reading Thursday Wrap-Up (March 15, 2012): Noteworthy Trade Secret, Non-Compete and Cybersecurity Stories from Around the Web

Allergan, Inc. v. Merz Pharmaceuticals: Central District of California Hammers Merz for Failure to Timely Produce Documents and Misappropriation of Trade Secrets and Halts Rollout of Xeomin for Ten Months
Continue Reading Allergan, Inc. v. Merz Pharmaceuticals: Central District of California Hammers Merz for Failure to Timely Produce Documents and Misappropriation of Trade Secrets and Halts Rollout of Xeomin for Ten Months